Helicobacter pylori infection, atrophic gastritis, and disabling dementia: the Japan Public Health Center-based Prospective Study.
Takashi Matsunaga, Kazumasa Yamagishi, Hiroyasu Iso, Nobufumi Yasuda et al.
Kernaussage
The combination of H. pylori infection, subsequent atrophic gastritis, and low vitamin B12 intake may be linked to an increased risk of disabling dementia.
Abstract
A meta-analysis reported a positive association between Helicobacter pylori (H. pylori) infection and dementia incidence. H. pylori infection leads to atrophic gastritis (AG) and affects the absorption of nutrients needed for nerve growth, such as vitamin B12 and folate. We aimed to clarify the associations of H. pylori IgG titer, AG, and their combination with disabling dementia incidence and to examine the interaction with vitamin B12 and folate. Anti-H. pylori immunoglobulin G (IgG) titer and pepsinogen levels were measured in 6,817 participants in 1993 (40-69 years), and the incidence of disabling dementia was followed during a median follow-up of 11.0 years. Associations of anti-H. pylori IgG titer, AG, and their combination with disabling dementia were examined using a multivariable-adjusted Cox proportional hazard model, with stratified analyses by dietary intake of vitamin B12 and folate. 1,325 (19.4%) developed disabling dementia during the follow-up period from 2006 to 2016. Among participants with low vitamin B12 intake, H. pylori infection and severe AG were positively associated with the risk of disabling dementia, with HRs of 1.26 (95% CI: 1.01-1.58) for H. pylori infection (H. pylori IgG titer ≥10 U/mL) and 1.34 (95% CI: 1.06-1.68) for severe AG. Additionally, having both H. pylori infection and AG was associated with an increased risk of dementia among individuals consuming less vitamin B12 than the median (HR 1.30, 95% CI: 1.05-1.61), compared with H. pylori-seronegative and AG-negative. The combination of H. pylori infection, subsequent AG, and low vitamin B12 intake may be related to increased risk of dementia.
Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.
Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.
Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.